AG Jackley Joins National Attorneys General Investigation On Opioids
PIERRE, S.D. – Attorney General Marty Jackley is working with a bipartisan coalition of Attorneys General from across the country in an investigation to evaluate whether manufacturers have engaged in unlawful practices in the marketing and sale of opioids. The Attorneys General are investigating what role the opioid manufacturers may have played in creating or prolonging this epidemic.
“There is a growing national opiate epidemic that is affecting South Dakota and our families and communities,” said Jackley. “Although we have worked hard as a State on the prevention of prescription drug abuse with our doctors, pharmacists and our Prescription Drug Monitoring Program, I remain concerned on the public health reports coming out of Ohio. Working with other State Attorneys General to investigate the facts and to find solutions will benefit us all.”
The State of South Dakota is proactively working to keep the opioid epidemic at bay. Some local efforts include the Prescription Drug Monitoring Program (PDMP), which provides physicians and pharmacists the opportunity to voluntarily access the prescription repository in order to have available additional medical history. At the request of Attorney General Jackley, the PDMP was passed into law during the 2010 legislative session. The purpose of this program was to improve patient care by providing physicians and pharmacists with a controlled substance dispensing history for their patients
Secondly, Attorney General Jackley sponsored legislation in 2015 that would enable all first responders to carry naloxone, a medicine to reverse the effects of opioid overdoses. Having naloxone available is a cost-effective way to save lives especially to our rural first responders. The Attorney General’s Office has authorized the use of available drug control funds to assist units of local government and first responders with the purchase of the Narcan agent.
The State of South Dakota is currently working on a Prescription Opioid Abuse Prevention Initiative and as part of that, the Attorney General’s Office is a participating member of Opioid Advisory Committee. The Committee is reviewing opioid use data for the state and developing strategies for preventing prescription opioid misuse and